|
82
|
260
|
9vtuA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with compound 20a and grip peptide |
|
88
|
324
|
9voxA |
Egfr t790m/l858r mutant in complex with covalent inhibitor tas-2913 |
|
84
|
258
|
9vt5A |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with compound 4 and grip peptide |
|
87
|
324
|
9vozA |
Egfr t790m/l858r mutant in complex with covalent inhibitor tas-121 |
|
90
|
324
|
9voyA |
Egfr t790m/l858r mutant in complex with covalent inhibitor tas6417 |
|
0
|
13
|
9vflB |
Crystal structure of plcg1 sh2(c) domain with a triple tyr phosphorylated peptide derived from ntrk1 |
|
21
|
95
|
9vflA |
Crystal structure of plcg1 sh2(c) domain with a triple tyr phosphorylated peptide derived from ntrk1 |
|
64
|
170
|
9s84A |
Crystal structure of kras g12d d38c (gdp-bound) |
|
48
|
166
|
9z5wA |
Crystal structure of hras in complex with n-lhy affibody |
|
61
|
166
|
9zpeA |
Kras g12v mutant in complex with gdp and compound 8. |
|
64
|
168
|
9zpaA |
Kras g12v mutant in complex with gdp and compound 12. |
|
66
|
166
|
9zo9A |
Kras g13d mutant in complex with gdp and compound 6. |
|
21
|
56
|
9z5wB |
Crystal structure of hras in complex with n-lhy affibody |
|
182
|
580
|
9n0yA |
Pp2a-b55 holoenzyme with eya3 |
|
83
|
309
|
9n0yC |
Pp2a-b55 holoenzyme with eya3 |
|
1
|
22
|
9n0yD |
Pp2a-b55 holoenzyme with eya3 |
|
51
|
439
|
9n0yB |
Pp2a-b55 holoenzyme with eya3 |
|
79
|
385
|
9hneC |
Cereblon in complex with ddb1, gspt1 and compound-1 |
|
54
|
167
|
9c40A |
Crystal structure of gdp-bound kras g12d/v103y: suppressing g12d oncogenicity via second-site v103y mutation |
|
59
|
167
|
9c3kA |
Crystal structure of gdp-bound kras g12d/m67r: suppressing g12d oncogenicity via second-site m67r mutation |
|
62
|
168
|
9c3mA |
Crystal structure of gdp-bound kras g12d/f28k: suppressing g12d oncogenicity via second-site f28k mutation |
|
62
|
168
|
9c3nA |
Crystal structure of gdp-bound kras g12d/p34r: suppressing g12d oncogenicity via second-site p34r mutation |
|
56
|
167
|
9c3rA |
Crystal structure of gdp-bound kras g12d/v45e: suppressing g12d oncogenicity via second-site v45e mutation |
|
65
|
169
|
9c43A |
Crystal structure of gdp-bound kras e3k/g12d: suppressing g12d oncogenicity via second-site e3k mutation |
|
65
|
170
|
9c3qA |
Crystal structure of gdp-bound kras g12d/r41q: suppressing g12d oncogenicity via second-site r41q mutation |
|
52
|
166
|
9c3vA |
Crystal structure of gdp-bound kras g12d/d54r: suppressing g12d oncogenicity via second-site d54r mutation |
|
61
|
168
|
9c3zA |
Crystal structure of gdp-bound kras g12d/g60r: suppressing g12d oncogenicity via second-site g60r mutation |
|
65
|
167
|
9c41A |
Crystal structure of gdp-bound kras g12d/e62q: suppressing g12d oncogenicity via second-site e62q mutation |
|
41
|
148
|
9rkeC |
Crystal structure of compound 1-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
24
|
96
|
9rk8B |
Crystal structure of compound 3-mediated ternary complex of kras g12v c118s gdp with pvhl:elonginc:elonginb |
|
25
|
96
|
9rkcB |
Crystal structure of acbi4-mediated ternary complex of kras g12d c118s gdp with pvhl:elonginc:elonginb |
|
35
|
148
|
9rkjC |
Crystal structure of compound 3-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
52
|
168
|
9rknD |
Crystal structure of acbi4-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
54
|
168
|
9rkjD |
Crystal structure of compound 3-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
46
|
168
|
9rk8D |
Crystal structure of compound 3-mediated ternary complex of kras g12v c118s gdp with pvhl:elonginc:elonginb |
|
60
|
168
|
9rkcD |
Crystal structure of acbi4-mediated ternary complex of kras g12d c118s gdp with pvhl:elonginc:elonginb |
|
23
|
104
|
9rkeA |
Crystal structure of compound 1-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
58
|
168
|
9rkeD |
Crystal structure of compound 1-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
37
|
146
|
9rknC |
Crystal structure of acbi4-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
23
|
104
|
9rkcA |
Crystal structure of acbi4-mediated ternary complex of kras g12d c118s gdp with pvhl:elonginc:elonginb |
|
36
|
147
|
9rk8C |
Crystal structure of compound 3-mediated ternary complex of kras g12v c118s gdp with pvhl:elonginc:elonginb |
|
18
|
103
|
9rk8A |
Crystal structure of compound 3-mediated ternary complex of kras g12v c118s gdp with pvhl:elonginc:elonginb |
|
21
|
104
|
9rknA |
Crystal structure of acbi4-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
39
|
146
|
9rkcC |
Crystal structure of acbi4-mediated ternary complex of kras g12d c118s gdp with pvhl:elonginc:elonginb |
|
26
|
96
|
9rkjB |
Crystal structure of compound 3-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
23
|
96
|
9rknB |
Crystal structure of acbi4-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
27
|
96
|
9rkeB |
Crystal structure of compound 1-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
17
|
104
|
9rkjA |
Crystal structure of compound 3-mediated ternary complex of kras g12r gcp with pvhl:elonginc:elonginb |
|
134
|
631
|
9p9uA |
Egfr-kdd with compound2 |
|
134
|
416
|
9kerA |
Crystal structure analysis of phosphoglycerate kinase 1 |
